Sanofi’s Immuneering Corp Position
Does Sanofi own Immuneering Corp (IMRX)? Yes — 2.71M shares worth $14M (+4.25% of its 13F portfolio) as of Q1 2026.
Position Value
$14M
Q1 2026
Shares
2.71M
% of Portfolio
+4.25%
Quarters Held
3
currently held
Position History IMRX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sanofi’s full portfolio or all institutional holders of IMRX.